Free Trial

Harmony Biosciences Q4 2024 Earnings Report

Harmony Biosciences logo
$29.26 -1.71 (-5.51%)
As of 11:52 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Harmony Biosciences EPS Results

Actual EPS
$0.85
Consensus EPS
$0.74
Beat/Miss
Beat by +$0.11
One Year Ago EPS
$0.45

Harmony Biosciences Revenue Results

Actual Revenue
$201.30 million
Expected Revenue
$201.25 million
Beat/Miss
Beat by +$52.00 thousand
YoY Revenue Growth
+19.50%

Harmony Biosciences Announcement Details

Quarter
Q4 2024
Time
Before Market Opens
Remove Ads

Harmony Biosciences Earnings Headlines

Here’s How to Claim Your Stake in Elon’s Private Company, xAI
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.
See More Harmony Biosciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Harmony Biosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Harmony Biosciences and other key companies, straight to your email.

About Harmony Biosciences

Harmony Biosciences (NASDAQ:HRMY), a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.

View Harmony Biosciences Profile

More Earnings Resources from MarketBeat